Cell Lines Used in This Study
| . | Cell Line . | Source . |
|---|---|---|
| Lymphoid cells | ||
| Non-B non-T precursor cells | Reh | A |
| Pre-B cells | Nalm-6 | B |
| SMS-SB | B | |
| LBW-2 | B | |
| Mature B cells | BALL-1 | C |
| Burkitt cells | Namalwa | D |
| Ramos | B | |
| B-lymphoid cells | HA | E |
| Myeloma or plasma cells | IM-9 | E |
| HS-sultan | F | |
| t(11; 14)(q13; q32)-bearing myeloma cells | SP-49 | G |
| FLAM-76 | G | |
| T cells (I)* | P30/Ohkubo | F |
| T cells (II) | CEM | C |
| RPMI8402 | H | |
| HPB-ALL | E | |
| T cells (III) | KOPT-K1 | H |
| MOLT-3 | C | |
| Jurkat | C | |
| MOLT-4 | I | |
| MOLT-16 | E | |
| T cells (IV) | PEER | H |
| SKW-3 | E | |
| A3/Kawakami | E | |
| HTLV-1–infected T cells (V) | MT-1 | C |
| MT-2 | C | |
| HUT102 | C | |
| Myeloid cells | ||
| Myeloblast cells | KG-1 | F |
| K562 | F | |
| KCL-22 | D | |
| Promyelocytic cells | HL-60 | F |
| Monocytic cells | JOSK-K | E |
| JOSK-S | E | |
| JOSK-I | E | |
| THP-1 | F | |
| Histiocytic cells | J111 | E |
| U937 | D | |
| Erythroid cells | JK-1 | I |
| HEL | F | |
| Megakaryoblastic cells | MEG01s | J |
| MEG01 | J | |
| CMK29 | K | |
| CMK11-5 | K | |
| Meg-J30 | L | |
| MOLM-1 | E |
| . | Cell Line . | Source . |
|---|---|---|
| Lymphoid cells | ||
| Non-B non-T precursor cells | Reh | A |
| Pre-B cells | Nalm-6 | B |
| SMS-SB | B | |
| LBW-2 | B | |
| Mature B cells | BALL-1 | C |
| Burkitt cells | Namalwa | D |
| Ramos | B | |
| B-lymphoid cells | HA | E |
| Myeloma or plasma cells | IM-9 | E |
| HS-sultan | F | |
| t(11; 14)(q13; q32)-bearing myeloma cells | SP-49 | G |
| FLAM-76 | G | |
| T cells (I)* | P30/Ohkubo | F |
| T cells (II) | CEM | C |
| RPMI8402 | H | |
| HPB-ALL | E | |
| T cells (III) | KOPT-K1 | H |
| MOLT-3 | C | |
| Jurkat | C | |
| MOLT-4 | I | |
| MOLT-16 | E | |
| T cells (IV) | PEER | H |
| SKW-3 | E | |
| A3/Kawakami | E | |
| HTLV-1–infected T cells (V) | MT-1 | C |
| MT-2 | C | |
| HUT102 | C | |
| Myeloid cells | ||
| Myeloblast cells | KG-1 | F |
| K562 | F | |
| KCL-22 | D | |
| Promyelocytic cells | HL-60 | F |
| Monocytic cells | JOSK-K | E |
| JOSK-S | E | |
| JOSK-I | E | |
| THP-1 | F | |
| Histiocytic cells | J111 | E |
| U937 | D | |
| Erythroid cells | JK-1 | I |
| HEL | F | |
| Megakaryoblastic cells | MEG01s | J |
| MEG01 | J | |
| CMK29 | K | |
| CMK11-5 | K | |
| Meg-J30 | L | |
| MOLM-1 | E |
Differentiation stage of T cells defined by Dr J. Minowada31 is shown in parentheses.
The sources of cell lines were as follows: (A) Dr M. Higashihara, First Department of Internal Medicine, University of Tokyo; (B) Dr T. Nakamura, First Department of Internal Medicine, University of Tokyo; (C) Dr M. Yoshida, Institute of Medical Science, University of Tokyo; (D) our lab; (E) Drs S. Ogawa and H. Hirai, Third Department of Internal Medicine, University of Tokyo; (F) Japanese Cancer Research Resource Bank; (G) Drs I. Kubonishi and I. Miyoshi, Department of Medicine, Kochi Medical School; (H) Dr Y. Hayashi, Department of Pediatrics, University of Tokyo; (I) Dr K. Tani, Institute of Medical Science, University of Tokyo; (J) Dr M. Ogura, Aichi Cancer Hospital and Dr H. Saito, First Department of Internal Medicine, Nagoya University; (K) Dr T. Sato, Department of Pediatrics, Chiba University; and (L) Drs M. Teramura and H. Mizoguchi, Department of Hematology, Tokyo Women's Medical School.